Clinical Trials Directory

Trials / Completed

CompletedNCT06585813

Implants Placement with Simultaneous Soft Tissue Augmentation Using a Collagen Matrix Compared to Connective Tissue Graft: a Pilot Study

Multiple Implant Placement with Simultaneous Soft Tissue Augmentation Using a Volume-stable Collagen Matrix Compared to Autogenous Connective Tissue Graft: a Clinical, Histological and Volumetric Pilot Study

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
4 (actual)
Sponsor
Saint-Joseph University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Background: To our knowledge, no study evaluated the use of VCMX at multiple implant sites and compared its efficacy and safety to a SCTG with the same dimensions. Therefore, we propose in the present protocol to evaluate the efficacy of VMCX to increase the thickness and height of soft tissue when placed at the time of multiple implant placement, as compared to SCTG. Material and Methods: This study will be conducted in the saint joseph university periodontology department on at least 5 to 10 patients. The studied sites are the edentulous posterior mandible in a split-mouth model. The test groups are the groups grafted with VCMX and the control groups are the groups grafted with SCTG. Some studies have been reported to compare these two techniques. But the specificity of our study is soft tissue augmentation on multiple implant sites in a split-mouth design.

Conditions

Interventions

TypeNameDescription
PROCEDUREdental implantwe placed our implants and simultaneously grafted either fibroguide or CTG and after 3 months we did the second stage surgery
PROCEDUREFibrogide membranewe were comparing the efficacy of Fibrogide with the Connective tissue graft
PROCEDUREconnective tissue graftthe control group was the connective tissue graft group and the test group was the Fibrogide group
PROCEDUREsecond stagesecond stage to determine the thickness gained after the graft and to place a healing abutment

Timeline

Start date
2022-10-10
Primary completion
2024-04-29
Completion
2024-06-20
First posted
2024-09-19
Last updated
2024-09-19

Locations

1 site across 1 country: Lebanon

Source: ClinicalTrials.gov record NCT06585813. Inclusion in this directory is not an endorsement.